Works matching DE "CYTARABINE"
Results: 1234
Anticancer and cancer preventive activities of shogaol and curcumin from Zingiberaceae family plants in KG-1a leukemic stem cells.
- Published in:
- BMC Complementary Medicine & Therapies, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12906-025-04829-7
- By:
- Publication type:
- Article
Editorial: Drug repurposing for cancer treatment: current and future directions.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1550672
- By:
- Publication type:
- Article
Fluorescent Clade IIb Lineage B.1 Mpox Viruses for Antiviral Screening.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 253, doi. 10.3390/v17020253
- By:
- Publication type:
- Article
Treatment of myeloid neoplasia with doxorubicin and cytarabine in 11 dogs.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 1, p. 54, doi. 10.1111/vco.12860
- By:
- Publication type:
- Article
Evaluation of a multi‐agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non‐Hodgkin high‐grade lymphomas: a single centre's experience.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 2, p. 165, doi. 10.1111/vco.12457
- By:
- Publication type:
- Article
A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E144, doi. 10.1111/vco.12360
- By:
- Publication type:
- Article
Safety of intrathecal administration of cytosine arabinoside and methotrexate in dogs and cats.
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, n. 3, p. 331, doi. 10.1111/vco.12109
- By:
- Publication type:
- Article
Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 3, p. 1, doi. 10.1002/hup.2824
- By:
- Publication type:
- Article
In vitro evaluation of copper sulfide nanoparticles decorated with folic acid/chitosan as a novel pH‐sensitive nanocarrier for the efficient controlled targeted delivery of cytarabine as an anticancer drug.
- Published in:
- Biotechnology & Applied Biochemistry, 2023, v. 70, n. 1, p. 330, doi. 10.1002/bab.2355
- By:
- Publication type:
- Article
Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.
- Published in:
- Clinical Pathology, 2024, p. 1, doi. 10.1177/2632010X241304564
- By:
- Publication type:
- Article
Efforts Underway To Curb Drug Shortages.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 12, p. 914, doi. 10.1093/jnci/djr234
- By:
- Publication type:
- Article
Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 11, p. 893, doi. 10.1093/jnci/djr107
- By:
- Publication type:
- Article
Tenth Biannual Report of the Cochrane Haematological Malignancies Group—Focus on Acute Myeloid Leukemia.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 20, p. E1, doi. 10.1093/jnci/djp347
- By:
- Publication type:
- Article
Rapidly ascending necrotizing myelopathy with widespread brain white matter involvement following intrathecal methotrexate and cytosine arabinoside treatment in an adult with T cell acute lymphoblastic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.
- Published in:
- Neurological Sciences, 2013, v. 34, n. 12, p. 2151, doi. 10.1007/s10072-013-1358-0
- By:
- Publication type:
- Article
Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findings.
- Published in:
- Neurological Sciences, 2012, v. 33, n. 2, p. 403, doi. 10.1007/s10072-011-0752-8
- By:
- Publication type:
- Article
Drug Shortage Impacts Patient Receipt of Induction Treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
DIAGNOSIS AND TREATMENT OUTCOME OF A DOG WITH MENINGOENCEPHALITIS OF UNKNOWN ORIGIN USING A COMBINATION OF PREDNISOLONE AND CYTOSINE ARABINOSIDE: A CASE STUDY.
- Published in:
- AgroLife Scientific Journal, 2020, v. 9, n. 2, p. 112
- By:
- Publication type:
- Article
Case Study: Molecular Profiling in Acute Myeloid Leukemia.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 2, p. 86
- By:
- Publication type:
- Article
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00982-3
- By:
- Publication type:
- Article
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00871-1
- By:
- Publication type:
- Article
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y
- By:
- Publication type:
- Article
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Core binding factor acute myelogenous leukemia-2021 treatment algorithm.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00503-6
- By:
- Publication type:
- Article
Venetoclax-based chemotherapy in acute and chronic myeloid neoplasms: literature survey and practice points.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00388-x
- By:
- Publication type:
- Article
Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Intake of oligoelements with cytarabine or etoposide alters dopamine levels and oxidative damage in rat brain.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61766-0
- By:
- Publication type:
- Article
DNA-PK Inhibitor, M3814, as a New Combination Partner of Mylotarg in the Treatment of Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00127
- By:
- Publication type:
- Article
Transcriptional Silencing of MCL-1 Through Cyclin-Dependent Kinase Inhibition in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01205
- By:
- Publication type:
- Article
Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01276
- By:
- Publication type:
- Article
Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00369
- By:
- Publication type:
- Article
Asymmetric Anterior Uveitis as a Delayed Complication of Treatment with Systemic High-dose Cytosine-Arabinoside: A Case Report and Literature Review.
- Published in:
- Ocular Immunology & Inflammation, 2014, v. 22, n. 4, p. 322, doi. 10.3109/09273948.2013.801990
- By:
- Publication type:
- Article
Anterior Uveitis Associated with High-dose Cytosine Arabinoside.
- Published in:
- Ocular Immunology & Inflammation, 2010, v. 18, n. 6, p. 485, doi. 10.3109/09273948.2010.510258
- By:
- Publication type:
- Article
Undetected Severe Fetal Myelosuppression following Administration of High-Dose Cytarabine for Acute Myeloid Leukemia: Is More Frequent Surveillance Necessary?
- Published in:
- Case Reports in Obstetrics & Gynecology, 2017, p. 1, doi. 10.1155/2017/5175629
- By:
- Publication type:
- Article
A Case of Acute Myeloid Leukemia with a Previously Unreported Translocation (14; 15) (q32; q13).
- Published in:
- 2014
- By:
- Publication type:
- Case Study
MEES' LINE FOLLOWING CHEMOTHERAPY.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Human herpesvirus-6 acute limbic encephalitis after unrelated umbilical cord blood transplantation successfully treated with ganciclovir.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1385, doi. 10.1038/bmt.2015.159
- By:
- Publication type:
- Article
Outcomes of EAM conditioned autologous haematopoietic SCT for lymphoma. A matched pairs retrospective single-centre study analysis.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1486, doi. 10.1038/bmt.2013.90
- By:
- Publication type:
- Article
Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 8, p. 1082, doi. 10.1038/bmt.2011.218
- By:
- Publication type:
- Article
Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 7, p. 923, doi. 10.1038/bmt.2010.243
- By:
- Publication type:
- Article
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 7, p. 1147, doi. 10.1038/bmt.2009.318
- By:
- Publication type:
- Article
Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
- Published in:
- Bone Marrow Transplantation, 2009, v. 44, n. 12, p. 785, doi. 10.1038/bmt.2009.83
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy after Three Consecutive Liver Transplantations.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States.
- Published in:
- PharmacoEconomics, 2019, v. 37, n. 2, p. 239, doi. 10.1007/s40273-018-0732-4
- By:
- Publication type:
- Article
Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Clinical pharmacokinetics of cytarabine formulations.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Forsaken Pharmaceutical: Glasdegib in Acute Myeloid Leukemia and Myeloid Diseases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.
- Published in:
- 2021
- By:
- Publication type:
- journal article